Back to search

Article

Novel Use of Siltuximab in a Patient with Somatic UBA1 Mutated VEXAS Syndrome

2024-10-16

Abstract excerpt

<title>Abstract</title> <p>VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is an increasingly recognized disorder that occurs due to somatic mutations of a ubiquitin-activating enzyme encoded by ubiquitin-like modifier activating enzyme 1 gene, <italic>UBA1</italic>. Clinical findings associated with VEXAS syndrome include recurrent fevers, polychondritis, periorbital edema, pleural effu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4c5344b8-b53c-55c3-89b4-b606d73a6f1b
DOI
10.21203/rs.3.rs-4952720/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel Use of Siltuximab in a Patient with Somatic UBA1 Mutated VEXAS SyndromeDOI 10.21203/rs.3.rs-4952720/v1
Select a neighboring publication to make it the new centre.